Annual ROA
2.89%
+24.43%+113.42%
December 1, 2023
Summary
- As of March 10, 2025, ORMP annual return on assets is 2.89%, with the most recent change of +24.43% (+113.42%) on December 1, 2023.
- ORMP annual ROA is now at all-time high.
Performance
ORMP ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
2.31%
-7.63%-76.76%
September 1, 2024
Summary
- As of March 10, 2025, ORMP quarterly return on assets is 2.31%, with the most recent change of -7.63% (-76.76%) on September 1, 2024.
- Over the past year, ORMP quarterly ROA has dropped by -0.57% (-19.79%).
- ORMP quarterly ROA is now -76.76% below its all-time high of 9.94%, reached on June 1, 2024.
Performance
ORMP Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
ORMP ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +113.4% | -19.8% |
| 3 y3 years | - | +109.4% |
| 5 y5 years | +108.3% | +106.6% |
ORMP ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.4% | -76.8% | +109.3% |
| 5 y | 5-year | at high | +108.3% | -76.8% | +106.1% |
| alltime | all time | at high | +100.1% | -76.8% | +100.4% |
Oramed Pharmaceuticals ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 2.31%(-76.8%) |
| Jun 2024 | - | 9.94%(+93.0%) |
| Mar 2024 | - | 5.15%(+78.8%) |
| Dec 2023 | 2.89%(-113.4%) | 2.88%(-131.2%) |
| Sep 2023 | - | -9.23%(-26.5%) |
| Jun 2023 | - | -12.55%(-30.3%) |
| Mar 2023 | - | -18.00%(-17.0%) |
| Dec 2022 | -21.54%(+182.3%) | -21.68%(-2.3%) |
| Sep 2022 | - | -22.18%(-9.9%) |
| Jun 2022 | - | -24.61%(+1.2%) |
| Mar 2022 | - | -24.31%(-2.3%) |
| Dec 2021 | -7.63%(-56.1%) | - |
| Nov 2021 | - | -24.88%(-20.4%) |
| Aug 2021 | -17.37%(-40.2%) | -31.25%(-6.9%) |
| May 2021 | - | -33.55%(-3.1%) |
| Feb 2021 | - | -34.61%(-8.2%) |
| Nov 2020 | - | -37.71%(+22.2%) |
| Aug 2020 | -29.03%(-17.0%) | -30.86%(+2.5%) |
| May 2020 | - | -30.11%(-16.3%) |
| Feb 2020 | - | -35.97%(+7.7%) |
| Nov 2019 | - | -33.39%(-4.7%) |
| Aug 2019 | -34.99%(+18.4%) | -35.03%(-4.3%) |
| May 2019 | - | -36.61%(-1.5%) |
| Feb 2019 | - | -37.15%(+5.3%) |
| Nov 2018 | - | -35.28%(+11.2%) |
| Aug 2018 | -29.56%(+15.0%) | -31.73%(-2.0%) |
| May 2018 | - | -32.38%(+28.2%) |
| Feb 2018 | - | -25.25%(+0.7%) |
| Nov 2017 | - | -25.08%(-0.4%) |
| Aug 2017 | -25.70%(+0.4%) | -25.18%(-17.4%) |
| May 2017 | - | -30.49%(-0.9%) |
| Feb 2017 | - | -30.78%(+11.5%) |
| Nov 2016 | - | -27.60%(-11.0%) |
| Aug 2016 | -25.60%(-6.7%) | -31.02%(+16.4%) |
| May 2016 | - | -26.64%(-6.7%) |
| Feb 2016 | - | -28.56%(-11.9%) |
| Nov 2015 | - | -32.41%(+7.6%) |
| Aug 2015 | -27.44% | -30.13%(+2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| May 2015 | - | -29.50%(-3.1%) |
| Feb 2015 | - | -30.44%(+8.9%) |
| Nov 2014 | - | -27.95%(-6.7%) |
| Aug 2014 | -26.13%(-46.5%) | -29.97%(-3.0%) |
| May 2014 | - | -30.91%(-18.5%) |
| Feb 2014 | - | -37.91%(-40.8%) |
| Nov 2013 | - | -64.03%(-0.6%) |
| Aug 2013 | -48.87%(-22.6%) | -64.39%(-22.7%) |
| May 2013 | - | -83.25%(+5.2%) |
| Feb 2013 | - | -79.11%(-8.3%) |
| Nov 2012 | - | -86.25%(-4.5%) |
| Aug 2012 | -63.16%(+75.0%) | -90.29%(+12.1%) |
| May 2012 | - | -80.53%(+84.8%) |
| Feb 2012 | - | -43.58%(+29.5%) |
| Nov 2011 | - | -33.64%(-21.7%) |
| Aug 2011 | -36.09%(-82.4%) | -42.95%(-35.9%) |
| May 2011 | - | -67.01%(-54.1%) |
| Feb 2011 | - | -145.98%(-8.3%) |
| Nov 2010 | - | -159.27%(+21.1%) |
| Aug 2010 | -205.21%(+142.5%) | -131.53%(+61.5%) |
| May 2010 | - | -81.43%(+28.3%) |
| Feb 2010 | - | -63.46%(-3.6%) |
| Nov 2009 | - | -65.81%(-12.7%) |
| Aug 2009 | -84.63%(+68.3%) | -75.41%(-12.0%) |
| May 2009 | - | -85.71%(-10.7%) |
| Feb 2009 | - | -95.97%(-7.0%) |
| Nov 2008 | - | -103.19%(+4.6%) |
| Aug 2008 | -50.29%(-69.9%) | -98.64%(-53.3%) |
| May 2008 | - | -211.28%(-13.0%) |
| Feb 2008 | - | -242.93%(-20.4%) |
| Nov 2007 | - | -305.14%(-26.8%) |
| Aug 2007 | -167.06%(-29.0%) | -416.73%(+42.4%) |
| May 2007 | - | -292.63%(-48.6%) |
| Feb 2007 | - | -569.06%(+28.8%) |
| Nov 2006 | - | -441.83%(-2.1%) |
| Aug 2006 | -235.30%(-93.3%) | -451.14%(+114.5%) |
| May 2006 | - | -210.34% |
| Aug 2005 | -3523.08% | - |
FAQ
- What is Oramed Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual ROA year-on-year change?
- What is Oramed Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly ROA year-on-year change?
What is Oramed Pharmaceuticals annual return on assets?
The current annual ROA of ORMP is 2.89%
What is the all time high annual ROA for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual return on assets is 2.89%
What is Oramed Pharmaceuticals annual ROA year-on-year change?
Over the past year, ORMP annual return on assets has changed by +24.43% (+113.42%)
What is Oramed Pharmaceuticals quarterly return on assets?
The current quarterly ROA of ORMP is 2.31%
What is the all time high quarterly ROA for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly return on assets is 9.94%
What is Oramed Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, ORMP quarterly return on assets has changed by -0.57% (-19.79%)